Fig. 6From: Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosisHydroxylated long chain acylcarnitines in samples of LCHADD patients versus controls; *ā=āsignificant difference pĀ <ā0.05Back to article page